HomeNews & TopicsHealth Care PolicyHow BD is Advancing the World of Health™ in the Face of...

How BD is Advancing the World of Health™ in the Face of Supply Chain Challenges

Published on

*Sponsored Content

By Ivy Parks, President, BD-Canada

The COVID-19 pandemic has created unprecedented challenges for Canada’s health care systems and supply chains across all industries globally. Similarly, medical technology companies have not been immune to these challenges. BD, one of Canada’s top suppliers to hospitals and other healthcare facilities, is working diligently to mitigate these challenges so healthcare providers can continue to deliver uninterrupted patient care.

BD is taking action to help address the medical technology demand surge and market dynamics by investing $1 billion in our global manufacturing capacity and nearly $150M in sterilization capabilities. In key critical product categories such as blood collection tubes, BD has taken action to maximize production – for example, worldwide our company has produced nearly 500 million additional blood tubes in 2021 versus 2020, and we will produce even more over the next 12 months. Our top priority is meeting the needs of patients by ensuring our customers have continued access to the most critical medical technology. To meet this goal, we have shifted specific production away from lower priority medical technology products to increase capacity for the highest demand products, and to help improve lead times and supply; we have been streamlining our portfolio for greater consistency, quality and efficiency.

As we navigate through these challenges, we continue to work closely with health system leaders, suppliers, transportation providers and the Canadian federal and provincial governments to minimize the impact of these unprecedented supply chain issues.

For our partners, we will continue to provide regular updates to ensure you are being kept aware of any key developments. As a result of our investments, and the systems and processes we have put in place, we are confident we will emerge from the COVID-19 pandemic with you stronger, together.

To learn more about action BD is taking to address medical technology supply chain challenges in Canada and to receive up-to-date information, please visit https://go.bd.com/COVID-19-hub-Canada.html.

Latest articles

Can mRNA Vaccines Help Treat Pancreatic Cancer?

Pancreatic cancer remains one of the most difficult cancers to treat. It is often...

How AI is transforming patient care in Canada—before the first visit

HN Summary • New study reveals most Canadians don’t turn to AI for mental health...

Improving Patient Experience Starts with How Teams Communicate

Healthcare teams are being asked to do more with less. Staffing shortages, rising patient...

Still managing fax referrals manually?

Despite decades of digital transformation initiatives, one technology still dominates referral intake across hospitals...

More like this

How Health Care Leaders Can Build a Robust AI Risk Management Framework

Artificial intelligence is rapidly moving from pilot projects to enterprise-wide deployment in health care....

Growing pressures facing hospital sector

At recent  2026/27 Pre-Budget Consultations, held by the Ministry of Finance in North York,...

Reporting saves lives: Pushing for safer, more transparent hospitals

HN Summary • Unintended harm remains a serious challenge, affecting 1 in 17 hospitalizations—about 153,000...

Canadian doctors call on Ontario government to reconsider new residency policy

The Canadian Medical Association and the College of Family Physicians of Canada are adding...

Canada needs coordinated primary care – now

We must strengthen the primary care foundation while building an integrated health system –...

Researchers launch intersex health communication guide

The new resource sets a national standard for inclusive, patient-centred care Researchers at McGill’s Centre...